To Compare the Efficacy and Safety of Tripterygium (TW) Versus Valsartan in the Diabetic Nephropathy (DN)
NACompletedINTERVENTIONAL
Enrollment
67
Participants
Timeline
Start Date
July 31, 2007
Primary Completion Date
September 30, 2009
Study Completion Date
March 31, 2010
Conditions
Diabetic Nephropathy
Interventions
DRUG
TW
TW,120 mg/d
Trial Locations (1)
210002
Research Institute of Nephrology, Nanjing
All Listed Sponsors
lead
Nanjing University School of Medicine
OTHER
NCT00518362 - To Compare the Efficacy and Safety of Tripterygium (TW) Versus Valsartan in the Diabetic Nephropathy (DN) | Biotech Hunter | Biotech Hunter